Switching from Buprenorphine to Suboxone: A Study
Author Information
Author(s): Kaarlo Simojoki, Helena Vorma, Hannu Alho
Primary Institution: A-clinic Foundation, Espoo, Finland
Hypothesis
Does switching patients from buprenorphine to the buprenorphine/naloxone combination affect treatment outcomes and misuse potential?
Conclusion
The study suggests that careful planning is needed when transferring patients from buprenorphine to Suboxone, as dose adjustments may be necessary and the combination product appears to have a lower abuse potential.
Supporting Evidence
- 90.6% of patients switched to Suboxone at the same dose as Subutex.
- 50% of patients reported adverse events during the first 4 weeks.
- Only one patient discontinued treatment due to adverse events during the 4-week study period.
Takeaway
This study looked at what happens when people switch from one medicine for addiction to another. It found that some people might need different doses and that the new medicine might be safer.
Methodology
Retrospective study involving data collection from 64 opioid-dependent patients who switched from Subutex to Suboxone across five treatment centers.
Potential Biases
Potential bias due to the retrospective nature and reliance on patient records.
Limitations
The study is retrospective with no control groups, and the sample size is relatively small.
Participant Demographics
{"gender":{"male":52,"female":null},"mean_age":29.9,"duration_of_heroin_use_mean":72.2}
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website